Who Owns IOBT?

IO Biotech, Inc. — Institutional Ownership & 13F Holdings

$0.01

+0.01 (+30.65%)

Market Cap

$886K

Shares Outstanding

71,948,842

Institutional Holders

21

Total Inst. Value

$18.5M

% of Float Held

31.6%

QoQ Holder Change

+5

Institutional data as of Q1 2025

New Positions

1

Closed Positions

6

Increased

3

Decreased

8

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Vivo Capital, LLC$6.7M6,173,439
2Novo Holdings A/S$3.7M3,354,449
3PFM Health Sciences, LP$2.6M2,341,107
4BANK OF AMERICA CORP /DE/$1.8M1,651,515
5Pivotal bioVenture Partners Investment Advisor LLC$942K864,197
6MORGAN STANLEY$860K789,461
7Dauntless Investment Group, LLC$743K681,446
8LANDSCAPE CAPITAL MANAGEMENT, L.L.C.$436K400,234
9Soleus Capital Management, L.P.$210K192,670
10RENAISSANCE TECHNOLOGIES LLC$138K126,400

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold IOBT?

As of Q1 2025, 21 institutional investors report holding IOBT (IO Biotech, Inc.) in their 13F filings.

What percentage of IO Biotech, Inc. is owned by institutions?

Institutional investors hold approximately 31.6% of IO Biotech, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most IOBT?

The largest institutional holder of IOBT is Vivo Capital, LLC with $6.7M in shares.

Are institutions buying or selling IOBT?

This quarter, 1 institutions opened new positions in IOBT and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.